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Summary
The development of selective COX-2 inhibitors has renewed interest in the treatment of osteoarthritis with prostaglandin synthesis inhibitors.
The therapeutic effects of COX inhibitors in OA may be due to their analgesic properties. However, it is now apparent that stable
prostaglandins are produced by chondrocytes in OA cartilage where they may act to alter matrix synthesis and degradation. In vitro, PGEs
activate metalloproteinases, but also enhance proteoglycan and type II collagen synthesis. Their net effect on matrix homeostasis in vivo
remains to be determined.
Key words: Cycloxygenase, Prostaglandins, Osteoarthritis, Cartilage.Introduction
There is evidence that inflammation plays a significant role
in the progression of osteoarthritis. Histologically, reactive
and inflammatory changes of the synovium are commonly
observed both by arthroscopy and in surgical specimens.
Chondrocytes of osteoarthritic cartilage are also the site of
inflammatory mediator production. It is the production of
inflammatory mediators, including IL-1, nitric oxide and
prostaglandins, by synovium and cartilage that appear to
drive the catabolic changes that characterize disease pro-
gression in osteoarthritis. The effects of these mediators on
cartilage will be the focus of this review.Materials and methods
Organ culture was conducted as previously described.1
Briefly, knee articular cartilage, from patients with OA or RA
undergoing knee replacement surgery, was obtained and
cut into 3-mm discs; four to six discs (~ 100 mg) were
placed in organ culture in 2 ml medium for 24 to 72 h, with
or without modulators. The medium was analyzed for
nitrite, PGE2 by RIA (Sigma Kit, Sigma, St. Louis, MO), and
IL-8 and TNF-a by ELISA (R&D Systems, Minneapolis,
MN).Prostaglandins are produced by OA cartilage
Among human cell types chondrocytes are sites of
prodigious prostaglandin and nitric oxide production follow-
ing exposure to IL-1. There are parallels between the
regulation of nitric oxide synthase (NOS) and cyclooxy-
genase (COX) isoforms, in that there are constitutive forms
of COX and NOS (e.g., in brain, endothelium) that partici-
pate in physiological functions, while the induced isoforms380are upregulated by inflammatory cytokines and partici-
pate in pathological processes.2–7 Thus, although their
effects are distinct both iNOS and COX-2 play roles in
inflammation, neoplasia, and apoptosis.7
The expression of COX-1 and COX-2 in OA synovial
tissue has been examined by Siegle et al., who reported
that COX-1 is expressed in synovial lining cells derived
from patients with both OA and RA.8 COX-2 expression is
marked in the synovium from RA, but not OA patients.
However, COX-2 is upregulated in chondrocytes present in
both OA and RA cartilage specimens.9 Moreover, OA
cartilage specimens spontaneously produced significant
amounts of PGE2.9 The amount of PGE2 produced
spontaneously by OA explant cultures, measured as
ng/100 mg of cartilage, was five to tenfold higher than that
produced by normal cartilage stimulated with IL-1.9 Prosta-
glandin production could be shown by RTPCR, Western
blot and partial cDNA sequencing to be due to COX-2
expression in OA cartilage. Consistent with the upregu-
lation of both iNOS and COX-2 endproduct production was
blocked by cycloheximide. As expected, the production of
PGE2 was blocked by the COX nonselective inhibitor 5 uM
indomethacin and dexamethasone.
We were interested in whether there was cross-talk
between nitric oxide and cyclooxygenase in OA cartilage.
The inhibition of PGE production by indomethacin had no
effect on the production of NO by OA explant cultures. In
contrast, the inhibition of NO production by L-NMMA
resulted in a two-fold increase in PGE2 production. These
observations were confirmed in a murine macrophage cell
line (RAW.274), in results comparable to those previously
reported by others, including Vane and co-workers.10,11 In
our studies the inhibition of NO production in stimulated
macrophages increased PGE2 production and increased
COX-2 protein expression.Reprint requests can be addressed to: Hospital for Joint Dis-
eases, 301 East 17th Street, New York, NY 10003. Tel: (212)
598-6119; Fax: (212) 598-6582; E-mail: steven.abramson@
med.NYUThe effects of prostaglandins in cartilage
What are the effects of prostaglandin overproduction in
diseased cartilage? Certainly, in osteoarthritis their central
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inflammation since these are not cardinal features of this
disease. Rather, since cartilage is an avascular, aneural
tissue which is does not easily manifest heat, redness,
swelling and pain, it is more likely that prostaglandins act
locally in an autocrine/paracrine fashion to regulate matrix
homeostasis. There is to date a small literature that has
begun to examine the effects of prostaglandins on cartilage
metabolism. There is evidence in gastrointestinal epithelial
cells that prostaglandins activate and increase metallopro-
teinases, a property with clear potential implications for
osteoarthritis.12 Additional properties of PGE2 which have
been described in other cell types and which may have
relevance include inhibition of apoptosis, reduction of TGFâ
receptors, increased metastatic invasion.
In studies of chondrocytes, Di Battista has shown that
PGE2 increases proteoglycan production.13 We have
added exogenous PGE2 to OA explants in culture and
examined effects on stromelysin (MMP-3) production. Con-
sistent with the observations of DuBois in epithelial cells we
observed that PGE2 caused a dose dependent increase in
stromelysin production by cartilage.12,14,15
Hahn and co-workers have examined the effects of
prostaglandins on DNA synthesis (thymidine uptake) in a
rat chondrocyte line and observed that different prosta-
glandin end-products exert distinct effects.16 In their
studies PGE1 enhanced DNA synthesis while PGE2
suppressed it, and PGF2 a exhibited a dose dependent
biphasic response. These results accentuate the complex-
ity of attempting to determine the net effects of eicosanoids
in diseased tissue, and by extension, the consequences of
inhibiting their production. The resolution of this area in
osteoarthritis is of particular current importance given the
imminent availability of COX-2 selective drugs.References
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